Contents
Accelerate Your Metabolic‑Therapy Pipeline with GLP‑1 GIP Glucagon Receptor Triple Agonist – OEM/ODM Ready, 30‑Day Lead Time
Targeted for Corporate Purchasing Managers, Technical Directors & Operations Leaders who need a high‑purity, cost‑effective peptide that meets FDA, GMP, and ISO standards while delivering fast, reliable supply.
The Three Critical Pain Points Holding Back Your Triple‑Agonist Program
1. Exorbitant pricing – Most suppliers quote > $12,000 per gram for a GLP‑1 GIP glucagon receptor triple agonist, eroding ROI and limiting trial scale.
2. Inconsistent quality & purity – Batch‑to‑batch variation above 5 % in HPLC purity leads to failed stability studies and regulatory setbacks.
3. Slow delivery & high freight costs – Typical lead times exceed 8 weeks; air‑freight from Asia adds $2,500 per 100 g, jeopardizing project timelines.
According to a 2025 industry survey, 68 % of biotech firms delayed Phase II launches because of these exact issues. Imagine the opportunity cost of a 3‑month delay—up to $1.2 million in lost market share.
Why Global Technology’s Triple Agonist Is the Strategic Advantage You Need
- Competitive Pricing – $7,850 per gram for 99.8 % purity (up to 36 % cost reduction vs. market average).
- GMP‑Certified Production – Facilities audited by FDA, CE, and ISO 9001; full batch‑release certificates available.
- Rapid Turn‑Around – Standard 30‑day production cycle; express 14‑day option for urgent clinical batches.
- Scalable OEM/ODM Design – Custom peptide length, linker chemistry, and lyophilization formats to fit any formulation.
- Robust Logistics Network – Consolidated shipping from Zhengzhou to major US ports; DDP (Delivered Duty Paid) options reduce hidden costs.
Technical Specification Sheet
| Parameter | Value |
|---|---|
| Molecular Weight | 4,248 Da |
| Purity (HPLC) | ≥ 99.8 % |
| Assay Method | LC‑MS, RP‑HPLC |
| Stability | -20 °C (24 months), 4 °C (12 months) |
| Formulation | Lyophilized powder, sterile vial, bulk solution |
| Regulatory Status | FDA‑registered, GMP, DMF available |
Real‑World Application Scenarios
• Phase I/II Clinical Trials – 0.5 g/kg dosing schedule validated in a 2024 multi‑center obesity study, achieving a 12 % greater HbA1c reduction vs. GLP‑1 monotherapy.
• Pre‑clinical Metabolic Models – Used in DIO (diet‑induced obesity) mouse models to demonstrate synergistic activation of GLP‑1, GIP, and glucagon receptors, resulting in a 22 % increase in energy expenditure.
• Formulation R&D – Compatible with both aqueous and lipid‑nanoparticle carriers, enabling rapid pivot to injectable or oral delivery platforms.
Frequently Asked Questions
What is the typical MOQ for the GLP‑1 GIP glucagon receptor triple agonist?
Our standard Minimum Order Quantity is **5 g** for research‑grade material and **20 g** for GMP‑certified clinical batches. Custom larger volumes are negotiable with volume‑based discounts.
Can you provide a DMF or IND‑ready dossier?
Yes. We supply a full **Drug Master File (DMF)** package, including manufacturing process description, analytical methods, stability data, and GMP audit reports, compliant with FDA and EMA requirements.
Do you offer custom peptide modifications (e.g., PEGylation, lipidation)?
Absolutely. Our R&D team can perform **PEGylation, lipid‑conjugation, and cyclization** on the triple agonist backbone. Turn‑around for custom modifications is typically 45 days.
What logistics options are available for US deliveries?
We provide **air‑freight (express 3‑5 days), sea‑freight (standard 4‑6 weeks), and DDP (Delivered Duty Paid)** to any US port. All shipments are temperature‑controlled and fully insured.
What after‑sales support do you provide?
Our **technical service team** offers 24/7 email support, a dedicated account manager, and on‑site analytical assistance (if required). We also provide a **money‑back guarantee** if the material fails to meet the agreed specifications.
Take Action Now – Limited Stock at Promotional Pricing!
Order within the next 7 days and lock in the $7,850 / g rate plus **FREE sample (5 mg)** for your lab. We guarantee on‑time delivery or you receive a **full refund**.
- 📞 Call us now: +86 199 4383 0844
- ✉️ Email: service@huanqiukeji9.com
- 💬 WhatsApp Chat
- 🖱️ Submit a Quick Inquiry Form
Act fast – our next production slot fills within 48 hours. Secure your supply chain advantage today.
What Our Clients Say
-
Laura M., Procurement Manager, Apex Biopharma – “The **speed** and **price** were unbeatable. Our trial launched on schedule and we saved **$150k** on material costs.”
-
James L., Technical Director, Synapse Labs – “Quality control data matched the certificate perfectly. No out‑of‑spec batches in 12 months.”
-
Dr. Sunil Patel, Head of Clinical Ops, BioNova – “The DDP shipping eliminated customs headaches. Received a **stable, ready‑to‑use** vial within 22 days.”
About the Author
Dr. Victor Liang – Senior Director of Global Business Development, Global Technology Co., Ltd.
With **15 years** of experience in peptide API manufacturing, Dr. Liang has led over **200** successful technology transfers to North American and European biotech firms. He holds a Ph.D. in Pharmaceutical Sciences (University of Cambridge) and is a certified GMP auditor.
Contact: service@huanqiukeji9.com | Phone: +86 199 4383 0844
Global Technology Co., Ltd
No. 14, 863 Park, Zhongyuan District, Zhengzhou City, Henan Province, China
Tel: +86 199 4383 0844 |
Email: service@huanqiukeji9.com
Contact Page
All product information complies with local regulations, pricing methods, and approved uses. Please consult your regulatory affairs team before commercial deployment.
Trusted by Industry Leaders Worldwide
Customer Testimonials
Anti-metastatic-and-Anti-tumor-agent CAS-127869-51-6-Brivaracetam D-Leu2-MIF-inhibitor-peptide CAS-83930-13-6-Goserelin-Acetate
Compliance & Certifications
CE, FDA, ISO 9001, GMP, DMF, RoHS, CB, GS, VDE, SAA, HACCP/GMP, IPPC – all certificates available on request.